Epidemiology of β-lactamase producing isolates

Detalhes bibliográficos
Autor(a) principal: Roxo, Inês Abrantes Cravo
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/14879
Resumo: Multidrug resistant bacteria are an emerging problem worldwide, associated with prolonged stays in the hospital and inherent increased costs. Widely studied ESBL-producers, and the not so considered AmpC-producers are of extreme importance, and its epidemiology should be closely followed. The epidemiology of ESBL-producing isolates from patients over 65 attending the ER and diagnosed with a UTI, as well as the epidemiology of AmpC-producing isolates were assessed by the Vitek2® procedure of identification. For the AmpC positive isolates, confirmatory phenotypic test were performed, searching for the presence of an AmpC enzyme. High numbers of ESBL-producing isolates, detected in UTI patients over 65 years old are the main motive of concern, since these are recurrent visitors of hospitals and frequently live in nursing homes, which makes them potential carriers of multiresistant strains. The earlier hospital restricted problem has now become widely spread in the community, and requires further attention. As for the AmpC, although less frequent than ESBLs, its presence often masks the ESBL phenotype. Misevaluation and false reports induces wrong medication procedures and the consequent emergence of selected resistant strains. Also, the possibility of identifying both resistance mechanisms in one organism has become more common, rising the need of complementary methods to distinguish them, which the automated method is unable to do. Cefoxitin disc was found to be the right complementary test to perform in order to detect these kinds of multiresistant strains. xii This study shows the importance of following the epidemiology of β-lactamases, providing a realistic view on its dissemination trough the community and its implications in the health care system in our region.
id RCAP_8e3ab9d61e5584167c27c5bf69ab2b87
oai_identifier_str oai:ria.ua.pt:10773/14879
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Epidemiology of β-lactamase producing isolatesBiomedicina molecularBactérias gram-negativasAparelho urinário - InfecçõesMultidrug resistant bacteria are an emerging problem worldwide, associated with prolonged stays in the hospital and inherent increased costs. Widely studied ESBL-producers, and the not so considered AmpC-producers are of extreme importance, and its epidemiology should be closely followed. The epidemiology of ESBL-producing isolates from patients over 65 attending the ER and diagnosed with a UTI, as well as the epidemiology of AmpC-producing isolates were assessed by the Vitek2® procedure of identification. For the AmpC positive isolates, confirmatory phenotypic test were performed, searching for the presence of an AmpC enzyme. High numbers of ESBL-producing isolates, detected in UTI patients over 65 years old are the main motive of concern, since these are recurrent visitors of hospitals and frequently live in nursing homes, which makes them potential carriers of multiresistant strains. The earlier hospital restricted problem has now become widely spread in the community, and requires further attention. As for the AmpC, although less frequent than ESBLs, its presence often masks the ESBL phenotype. Misevaluation and false reports induces wrong medication procedures and the consequent emergence of selected resistant strains. Also, the possibility of identifying both resistance mechanisms in one organism has become more common, rising the need of complementary methods to distinguish them, which the automated method is unable to do. Cefoxitin disc was found to be the right complementary test to perform in order to detect these kinds of multiresistant strains. xii This study shows the importance of following the epidemiology of β-lactamases, providing a realistic view on its dissemination trough the community and its implications in the health care system in our region.As bactérias multirresistentes são um problema emergente por todo o mundo, associado a estadias prolongadas nos hospitais, e ao inerente aumento de custos. As bactérias produtoras de β-lactamases de espectro alargado, amplamente estudadas, e as produtoras de enzimas AmpC, não tão mencionadas, são objecto de grande importância, e a sua epidemiologia deve ser seguida de perto. A epidemiologia de bactérias produtoras de β-lactamases de espectro alargado de pacientes com mais de 65 anos que recorrem à Urgência com diagnóstico de infecção urinária, bem como a epidemiologia de estirpes produtoras de AmpC, foram avaliadas através do processo de identificação automática Vitek2®. Para os isolados AmpC positivos, testes fenotípicos confirmatórios foram usados para detectar a presença de enzimas AmpC. Os valores elevados de isolados produtores de β-lactamases de espectro alargado detectados em pacientes com infecção urinária e mais de 65 anos são o maior motivo de preocupação. Uma vez que estes recorrem frequentemente à Urgência ou vivem em lares, estes doentes são potenciais veículos de transmissão destas bactérias multirresistentes. Um problema que estava confinado ao ambiente hospitalar é, hoje em dia, foco de atenção por se encontrar espalhado por toda a comunidade. Quanto às bactérias produtoras de AmpC, embora sejam menos frequentes do que as produtoras de β-lactamases de espectro alargado, a sua presença pode mascarar a presença do fenótipo característico destas. A avaliação incorrecta induz à prescrição errada de medicamentos e ao consequente surgimento x de estirpes resistentes. Para além disso, existe a possibilidade de se detectarem ambos os mecanismos de resistência na mesma estirpe, aumentando a necessidade de se usarem métodos complementares que as distingam, uma vez que o método automático não é capaz de o fazer. O disco de Cefoxitina é o teste indicado para complementar a identificação da presença da enzima AmpC. Este estudo mostra a importância de estudar a epidemiologia das β-lactamases, e fornece uma visão realista da sua disseminação pela comunidade, bem como das suas implicações no sistema de saúde da região de Aveiro.Universidade de Aveiro2015-11-13T14:45:19Z2015-01-01T00:00:00Z2015info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/14879TID:201577070engRoxo, Inês Abrantes Cravoinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T11:27:20Zoai:ria.ua.pt:10773/14879Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:50:22.110665Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Epidemiology of β-lactamase producing isolates
title Epidemiology of β-lactamase producing isolates
spellingShingle Epidemiology of β-lactamase producing isolates
Roxo, Inês Abrantes Cravo
Biomedicina molecular
Bactérias gram-negativas
Aparelho urinário - Infecções
title_short Epidemiology of β-lactamase producing isolates
title_full Epidemiology of β-lactamase producing isolates
title_fullStr Epidemiology of β-lactamase producing isolates
title_full_unstemmed Epidemiology of β-lactamase producing isolates
title_sort Epidemiology of β-lactamase producing isolates
author Roxo, Inês Abrantes Cravo
author_facet Roxo, Inês Abrantes Cravo
author_role author
dc.contributor.author.fl_str_mv Roxo, Inês Abrantes Cravo
dc.subject.por.fl_str_mv Biomedicina molecular
Bactérias gram-negativas
Aparelho urinário - Infecções
topic Biomedicina molecular
Bactérias gram-negativas
Aparelho urinário - Infecções
description Multidrug resistant bacteria are an emerging problem worldwide, associated with prolonged stays in the hospital and inherent increased costs. Widely studied ESBL-producers, and the not so considered AmpC-producers are of extreme importance, and its epidemiology should be closely followed. The epidemiology of ESBL-producing isolates from patients over 65 attending the ER and diagnosed with a UTI, as well as the epidemiology of AmpC-producing isolates were assessed by the Vitek2® procedure of identification. For the AmpC positive isolates, confirmatory phenotypic test were performed, searching for the presence of an AmpC enzyme. High numbers of ESBL-producing isolates, detected in UTI patients over 65 years old are the main motive of concern, since these are recurrent visitors of hospitals and frequently live in nursing homes, which makes them potential carriers of multiresistant strains. The earlier hospital restricted problem has now become widely spread in the community, and requires further attention. As for the AmpC, although less frequent than ESBLs, its presence often masks the ESBL phenotype. Misevaluation and false reports induces wrong medication procedures and the consequent emergence of selected resistant strains. Also, the possibility of identifying both resistance mechanisms in one organism has become more common, rising the need of complementary methods to distinguish them, which the automated method is unable to do. Cefoxitin disc was found to be the right complementary test to perform in order to detect these kinds of multiresistant strains. xii This study shows the importance of following the epidemiology of β-lactamases, providing a realistic view on its dissemination trough the community and its implications in the health care system in our region.
publishDate 2015
dc.date.none.fl_str_mv 2015-11-13T14:45:19Z
2015-01-01T00:00:00Z
2015
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/14879
TID:201577070
url http://hdl.handle.net/10773/14879
identifier_str_mv TID:201577070
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de Aveiro
publisher.none.fl_str_mv Universidade de Aveiro
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137553776902144